Stockholm - Delayed Quote SEK
Biosergen AB (BIOSGN.ST)
0.2950
-0.0020
(-0.67%)
At close: April 25 at 4:39:51 PM GMT+2
Research Analysis
Earnings Estimate
Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.02 | -0.02 | -0.1 | -0.1 |
Low Estimate | -0.02 | -0.02 | -0.1 | -0.1 |
High Estimate | -0.02 | -0.02 | -0.1 | -0.1 |
Year Ago EPS | -0.05 | -0.04 | -0.15 | -0.1 |
Revenue Estimate
Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | 1.4M |
Low Estimate | -- | -- | -- | 1.4M |
High Estimate | -- | -- | -- | 1.4M |
Year Ago Sales | 693k | 479k | 2.5M | -- |
Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
Earnings History
Currency in SEK | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -0.1 | 0 | -- | 0 |
EPS Actual | -0.05 | -0.04 | -0.03 | -0.02 |
Difference | 0.05 | -0.04 | -- | -0.02 |
Surprise % | 50.00% | 0.00% | -- | 0.00% |
EPS Trend
Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.02 | -0.02 | -0.1 | -0.1 |
7 Days Ago | 0 | 0 | -0.1 | -0.1 |
30 Days Ago | 0 | 0 | -0.1 | -0.1 |
60 Days Ago | 0 | 0 | -0.1 | -0.1 |
90 Days Ago | 0 | 0 | -0.1 | -0.1 |
EPS Revisions
Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | 1 | 1 | -- | -- |
Down Last 30 Days | 1 | 1 | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
BIOSGN.ST | 60.00% | 50.00% | 33.33% | 0.00% |
S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Related Tickers
ZLDPF Zealand Pharma A/S
65.16
+1.02%
BVNRY Bavarian Nordic A/S
7.73
+0.52%
ALK-B.CO ALK-Abelló A/S
146.80
+0.07%
GUBRA.CO Gubra A/S
354.00
-2.53%
ASND Ascendis Pharma A/S
164.15
+2.31%
IRD Opus Genetics, Inc.
0.8402
+5.02%
GMAB Genmab A/S
20.59
+0.24%
OTLK Outlook Therapeutics, Inc.
1.5300
-1.29%
ZEAL.CO Zealand Pharma A/S
420.50
-1.06%
GMAB.CO Genmab A/S
1,347.00
+0.52%